Recombinant protein · Protein replacement: von Willebrand factor (VWF) · developed by Takeda
Apadamtase alfa is a recombinant human ADAMTS13 enzyme that cleaves von Willebrand factor at the Tyr1605-Met1606 bond in the A2 domain, reducing ultralarge VWF multimers that drive platelet binding. It is being studied in thrombotic thrombocytopenic purpura (TTP).
Summary written with AI from the sources listed at the end of this page.
Thrombotic Thrombocytopenic Purpura (TTP)
Updated Nov 8, 2026. Something wrong or missing? Report it on the TAK page.
See TAK's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
TAK catalysts and pipeline →